🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II study designed to evaluate the safety, tolerability, P...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-02-05
Trial ID
NCT07375758
Treatments Being Tested
In asthmatics with airway hyperresponsiveness and a "T2 immune signature" (...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2019-07-01
Trial ID
NCT03884842
Treatments Being Tested
The primary objective of this study is to assess the safety and outcomes of...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-06-01
Trial ID
NCT02292784
Hyperacusis is the intolerance to sound levels that normally are judged acc...
Status
Completed
Location
Univ. of Maryland - Baltimore
Start Date
2002-07
Trial ID
NCT00890526
This is a phase 1/2a double-blinded, placebo-controlled, dose-escalating st...
Status
Recruiting
Location
Liverpool Hospital
Start Date
2024-03-04
Trial ID
NCT06138743
Treatments Being Tested
To determine the effect of 12 weeks of chronic PDEV inhibition with Tadalaf...
Status
Completed
Location
Mayo Clinic
Start Date
2014-03
Trial ID
NCT02058095
The aim of the study is to assess the safety and tolerability of GSK1521498...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-13
Trial ID
NCT01366573
Treatments Being Tested
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Inves...
Status
Recruiting
Location
Laboratory for Muscle Diseases and Neuropathies
Start Date
2025-02-13
Trial ID
NCT06523400
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of sub...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-12
Trial ID
NCT07324850
Treatments Being Tested
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested